SEC Form 4 · accession 0001209191-19-003181
Nightstar Therapeutics plc · NITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tuyen Ong
Officer — Chief Development Officer
Period of report
Jan 7, 2019
Accepted (ET)
Jan 9, 2019 · 9:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711675
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 7, 2019 | S | 2,546 | $12.9808 | D | 82,925 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- F2This transaction was effected by the Reporting Person to cover tax liabilities pursuant to the Issuer's mandatory sell-to-cover policy.